Manufacturing
We have the unique capability to leverage multiple manufacturing facilities for our research and development and commercial manufacturing activities.
We have the unique capability to leverage multiple manufacturing facilities for our research and development and commercial manufacturing activities.
We have two in-house manufacturing facilities: a good manufacturing practice (GMP)-certified commercial manufacturing in Changxing, Zhejiang province, China, and a research and development and pilot manufacturing facility in Chengdu, Sichuan province, China.
· Our in-house, commercial-ready vaccines manufacturing facility in Changxing, Zhejiang province has passed multiple commercial GMP inspections;
· Received Drug Manufacturing License (DML) for vaccine production from Zhejiang Medical Products Administration;
· Received EU QP Declaration stating the facility operation complies with EU GMP standards.
Located in Chengdu, Sichuan province, our R&D and pilot manufacturing facility supplies materials for our pre-clinical and early-stage clinical trials. It occupies approximately 3,300 square meters and contains a 200 liter single-use and 150 liter stainless steel bioreactor capacity as well as multiple pilot-scale drug product filling lines.
